Glomerulonephritis, chronic N03.9

Last updated on: 16.07.2023

Dieser Artikel auf Deutsch

History
This section has been translated automatically.

Richard Bright was the first to describe chronic glomerulonephritis in 1831 (Singer 1999).

In 2002, M R Pollak summarized a group of congenital diseases with primary podocyte damage and nephrotic syndrome under the term "true podocytopathies". These include, for example, minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy (Chebotareva 2018).

Definition
This section has been translated automatically.

Chronic glomerulonephritis (CGN) refers to a chronic course of various glomerulopathies (Lohr 2002).

Classification
This section has been translated automatically.

Various grading systems exist to assess the chronicity of glomerulonephritis (Sethi 2019):

- Standardized grading of chronic changes in the kidney (Sethi 201).

- Global and segmental glomerulosclerosis (GS) are graded from 0 to 3

- Tubule shrinkage with thickening of tubular basement membrane and flattening of tubular epithelium (TA) scored 0 to 3

- Interstitial fibrosis (IF) with 0 to 3

- Arteriosclerosis with 0 to 1

Scores are summed (total renal chronicity score) to classify the overall severity of chronic lesions into minimal (0 - 1 total score), mild (2 - 4 total score), moderate (5 - 7 total score), and severe (≥ 8 total score)

(Sethi 2017)

- Oxford classification of IgA nephropathy (Sethi 2019):

Here, four variables are required for predicting renal outcome:

(1) the mesangial hypercellularity score

(2) segmental glomerulosclerosis

(3) endocapillary hypercellularity

(4) tubular atrophy/interstitial fibrosis (Roberts 2009).

- Modified International Society of Nephrology / Renal Pathology Society classification of lupus nephritis (Sethi 2019):

This classifies glomerular lesions into classes I - IV (Bajema 2018).

- Berden- Classification for ANCA associated glomerulonephritis (Sethi 2019):

This classification system divides biopsies into 4 different categories (Berden 2010).

Occurrence/Epidemiology
This section has been translated automatically.

The acute form of glomerulonephritis (GN) usually heals. Only about 1 % of affected children and about 10 % of affected adults develop a chronic course (O'Brien 2021).

Etiopathogenesis
This section has been translated automatically.

In most cases, CGN is caused by the same pathogens that can cause acute GN (O'Brien 2021):

- infectious glomerulonephritis

- genetic abnormalities

- autoimmune diseases

- however, in the vast majority of affected individuals, the cause remains unknown (O'Brien 2021).

Pathophysiology
This section has been translated automatically.

In CGN, inflammation develops in the tubules. Due to the limited regenerative capacity of the glomerular structures, the inflammation progresses. Damage to the postmitotic podocytes (Weltsch 2018) results in impaired barrier function of the glomerular filter, leading to proteinuria and erythrocyturia. The severity of proteinuria represents a clinical equivalent for the activity or progression of CGN. (Chebotareva 2018).

Clinical features
This section has been translated automatically.

The onset of the disease is usually gradual. Symptoms are only subtly expressed (O'Brien 2021).

There may be:

- erythrocyturia

- proteinuria

- arterial hypertension

- possibly nephrotic syndrome

In advanced stages, symptoms of renal insufficiency may occur, such as

- reduced physical performance

- edema

- dyspnea (Herold 2022)

- itching

- nausea

- Vomiting (O'Brien 2021).

Diagnostics
This section has been translated automatically.

In addition to anamnesis and clinical examination, laboratory parameters and abdominal sonography are of particular importance in the diagnosis. A biopsy is not (or no longer) indicated in most cases due to the lack of therapeutic consequences (Herold 2022).

Imaging
This section has been translated automatically.

Abdominal sonography

In CGN, the kidneys may appear inconspicuous on sonography for a prolonged period of time. Only as the disease progresses does a typically symmetrical organ shrinkage and narrowing of the parenchymal rim occur. Initially, the echo-poor medullary pyramids are still easily recognizable, but then there is an increasing homogeneous compression of the parenchymal rim pattern. In an advanced stage, changes of the surface, a coarsening of the parenchymal rim and poor differentiability of the renal sinus can be recognized (Seitz 2008).

Laboratory
This section has been translated automatically.

- Proteinuria

- erythrocyturia

- If necessary, determination of specific antibodies (O'Brien 2021)

- Increase in creatinine(Seitz 2008)

Histology
This section has been translated automatically.

In chronic diseases of the kidney, pathological changes are found both in the renal cortex, where they may affect glomeruli, tubules, interstitium, arteries and arterioles,

as well as in the renal medulla (Sethi 2017).

Segmental or global glomerulosclerosis is found in the glomeruli, and tubular atrophy and interstitial fibrosis in the interstitium (Sethi 2019).

General therapy
This section has been translated automatically.

The treatment of chronic glomerulonephritis is only possible symptomatically, whereby the control of arterial hypertension is of particular importance (Herold 2022).

Recommended drug therapy includes an ACE inhibitor or an angiotensin II receptor blocker (ARB), plus a low-salt diet. This often slows the progression of CGN, improves blood pressure, and reduces urinary protein excretion (O'Brien 2021).

Progression/forecast
This section has been translated automatically.

Cure of chronic glomerulonephritis is not possible. The disease progresses towards terminal renal failure (Herold 2022). The prognosis itself depends on the histologically confirmed underlying disease (Bichler 2004).

It is estimated that terminal renal failure develops in 25-50% of affected individuals (Halfon 2017).

Literature
This section has been translated automatically.

  1. Bajema I M, Wilhelmus S, Alpers C E, Bruijn J A, Colvin R B, Cook H T, D' Agati V D, Ferrario F, Haas M, Jennette J C, Joh K, Nast C C, Noel L H, Rijnink E C, Roberts I S, Seshan S V, Sethi S, Fogo A B (2018) Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Praczise Guideline Kidney Int. 93 (4) 789 - 796 doi: 10.1016/j.kint.2017.11.023.
  2. Berden A E, Ferrario F, Hagen E C, Jayne D R, Jennette J C, Joh K, Neumann I, Noel L H, Pusey C D, Waldherr R, Bruijn J A, Bajema I M (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 21 (10) 1628 - 1638
  3. Bichler K H, Kern B R, Strohmaier W L, Wechsel H W, Mattauch W, Flüchter S H, Rösner N, Seiter H, Naumann V, Risler T, Feil G, Weigl A, Lahme S, Zumbrägel A, Kalchthaler M, Witte W (2004) Das urologische Gutachten. Springer Verlag Berlin / Heidelberg / New York 97
  4. Chebotareva N V, Bobkova I N, Lysenko L V (2018) The role of podocytes dysfunction in chronic glomerulonephritis progression. Ter Arkh. 90 (6) 92 - 97
  5. Halfon M, Rotmann S, Pruijm M (2017) News for the general practitioner: glomerulonephritis. Switzerland Med Forum 17 (3) 298 - 305.
  6. Herold G et al (2022) Internal Medicine. Herold Publ. 615, 642
  7. Kasper D L, Fauci A S, Hauser S L, Longo D L, Jameson J L, Loscalzo J et al (2015) Harrison's Principles of Internal Medicine. Mc Graw Hill Education
  8. Lohr M (2002) GK 2 Pathophysiology - Pathobiochemistry. Original examination questions with commentary. Georg Thieme Publishers Stuttgart / New York
  9. O'Brien F (2021) Glomerulonephritis. MSD manual for professionals
  10. Roberts I S D, Cook H T, Troyanov S, Alpers C E, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn J A, Cattran D C, Coppo R, D' Agati V, D' Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza F C, Florquin S, Fogo A, Geddes C C, Groene H J, Haas M, Herzenerberg A M, Hill P A, Hogg R J, Hsu S I, Fennette J C, Joh K, Julian B A, Kawamura T, Lai F M, Li L S, Li P K T, Liu Z H, Mackinnon B, Mezzano S, Schena F P, Tomino Y, Walker P D, Wang H, Weening J J, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 76 (5) 546 - 556
  11. Seitz K, Schuler A, Rettenmaier G (2008) Clinical sonography and sonographic differential diagnosis. Volume I Georg Thieme Verlag Stuttgart 574
  12. Sethi S, D' Agati V D, Nast C C, Ronco P, Rovin B H, Haas M (2017) A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Policy Forum 91 (4) 787 - 789
  13. Sethi S, Fervenza F C (2019) Standardized classification and reporting of glomerulonephritis. Nephrology Dialysis Transplantation, Volume 34, Issue 2, 193 - 199.
  14. Singer M V et al (1999) Alcohol and alcohol sequelae: basic principles - diagnosis - therapy. Springer Verlag 383
  15. Weltsch U, Kummer W, Deller T (2018) Histology: cytology, histology and microscopic anatomy. The textbook Elsevier Urban und Fischer Verlag Germany 476.

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Last updated on: 16.07.2023